Skip to content
Enroll in Research
Get News
Search
Search
Search
Search
Close this search box.
Donate
Home
About
Dupuytren Disease and the Dupuytren Research Group
Vision, Mission, Values and Activities
Research Committee
Board of Directors
Staff and Support
Associations
Legal Documentation
Contact Us
For Patients
Patients
Dupuytren FAQs
Dupuytren Specialists
Enroll in the IDDB
Connect With Others
Dupuytren Advocacy
Patient Financial Support
For Professionals
Information for Scientists and Clinicians
DRG Literature Archives
Forms for Dupuytren Documentation
Request Dupuytren Research Group Patient Brochures
For Sponsors
Donate Page
Donor List
Information for Sponsors
Blog
Contact Us
Donate Now
Contact Us
Subscribe to eNewsletter
Request Brochures
Patient Financial Support
Donate
Donate
Dupuytren Advocacy
Donor List
Menu
Home
About
Dupuytren Disease and the Dupuytren Research Group
Vision, Mission, Values and Activities
Research Committee
Board of Directors
Staff and Support
Associations
Legal Documentation
Contact Us
For Patients
Patients
Dupuytren FAQs
Dupuytren Specialists
Enroll in the IDDB
Connect With Others
Dupuytren Advocacy
Patient Financial Support
For Professionals
Information for Scientists and Clinicians
DRG Literature Archives
Forms for Dupuytren Documentation
Request Dupuytren Research Group Patient Brochures
For Sponsors
Donate Page
Donor List
Information for Sponsors
Blog
Contact Us
Donate Now
Contact Us
Subscribe to eNewsletter
Request Brochures
Patient Financial Support
Donate
Donate
Dupuytren Advocacy
Donor List
Ending Dupuytren disease
December 20, 2018
4:48 pm
What must be done to end Dupuytren disease?
Share:
More Posts
Happy New Year from the Dupuytren Research Group!
Dupuytren in the Family: What are the Odds?
Happy Thanksgiving from the Dupuytren Research Group
Happy Birthday, Dupuytren, and Thanks for the Name!
Recent Dupuytren Publications
Mortality in patients with Dupuytren's disease in the first 5 years after diagnosis: a population-based survival analysis
The impact of rising NHS waiting list times on elective surgery for Dupuytren's disease
Comparing Complications and Patient Satisfaction Following Injectable Collagenase Versus Limited Fasciectomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis
Pain-Relieving Effects of Shockwave Therapy for Ledderhose Disease: An Ultrasound-Based Study of an Unusual Bilateral Case
Surgery, Needle Fasciotomy, or Collagenase Injection for Dupuytren Contracture : A Randomized Controlled Trial
Prev
Previous
PrecisionFDA Dupuytren Blog
Next
Happy Holidays from the Dupuytren Research Group
Next